Pure Global
CDSCO UID IMP/MD/2019/000511_02c065524b5d157cdf1cefa54280210d_3cebcc1e77f665e6d04ab397c6524cf9

Drug Eluting Stent

Abbott Healthcare Private Limited·Device Class Class D·India CDSCO·Brand: Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System
Registration details
UID
IMP/MD/2019/000511_02c065524b5d157cdf1cefa54280210d_3cebcc1e77f665e6d04ab397c6524cf9
Device class
Class D
Brand name
Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System
License holder
Abbott Healthcare Private Limited
Approving authority
CDSCO
Product information
The XIENCE PRIME, XIENCE PRIME SV, and XIENCE PRIME LL Everolimus Eluting Coronary Stent Systems are indicated for improving coronary luminal diameter in the following: • Patients with symptomatic ischemic heart disease due to discrete de novo native coronary artery lesions. • For restoring coronary flow in patients experiencing acute myocardial infarction who present within 12 hours of symptom onset. • For the treatment of patients with concomitant diabetes, acute coronary syndrome, dual vessel lesions (Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System), lesions residing within small coronary vessels; lesions where treatment results in the jailing of side branches (Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System); for the treatment of elderly patients (Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System), and for treatment of both men and women. • For the treatment of patients presenting with in-stent restenosis in coronary artery lesions; chronic total occluded coronary artery lesions (Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System); and coronary artery bifurcation lesions. In all cases, the treated lesion length should be less than the nominal stent length (Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System) with a reference vessel diameter of ≥ 2.25 mm and ≤ 4.25 mm
Similar products (10)
Other products with the same name or brand
Drug Eluting Stent
Brand: Sirolimus
CARDIOAXIS CORPORATION PVT LTD C/O FRISCH MEDICAL DEVICES PVT LTD
Class D
Drug Eluting Stent
Brand: Sirolimus
Frisch Medical Devices Pvt. Ltd C/O Newtech Medical Devices
Class D
Drug Eluting Stent
Brand: ClearEmbo
Newtech Medical Devices
Class D
Drug Eluting Stent
Brand: ClearEmbo
Newtech Medical Devices
Class D
Coronary Stent Graft System
Brand: Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System
Abbott Healthcare Private Limited
Class D
Coronary Stent System
Brand: Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System
Abbott Healthcare Private Limited
Class D
Coronary Stent System
Brand: Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System
Abbott Healthcare Private Limited
Class D
Drug Eluting Stent
Brand: Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System
Abbott Healthcare Private Limited
Class D
Drug Eluting Stent
Brand: Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System
Abbott Healthcare Private Limited
Class D
Drug Eluting Stent
Brand: Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System
Abbott Healthcare Private Limited
Class D
Other products from Abbott Healthcare Private Limited
Products from the same license holder (10 products)
LibreView software which includes LibreLinkUp mobile application
Class B
FreeStyle LibreLink app
Class B
Flash Glucose Monitoring System
Brand: FreeStyle Libre Pro
Class C
Flash Glucose Monitoring System
Brand: FreeStyle Libre Pro
Class C
CORONARY DILATATION CATHETER
Brand: NC TREK NEO™
Class C
Suture-Mediated Closure System
Brand: NC TREK NEO™
Class C
CORONARY DILATATION CATHETER
Brand: NC TREK NEO™
Class C
Drug Eluting Stents
Brand: Xience Alpine™ Everolimus Eluting Coronary Stent System
Class D
Drug Eluting Stents
Brand: Xience Alpine™ Everolimus Eluting Coronary Stent System
Class D
Drug Eluting Stents
Brand: Xience Alpine™ Everolimus Eluting Coronary Stent System
Class D
About this record

Drug Eluting Stent is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2019/000511_02c065524b5d157cdf1cefa54280210d_3cebcc1e77f665e6d04ab397c6524cf9. This device is marketed under the brand name Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System. The license holder is Abbott Healthcare Private Limited, and it is classified as Device Class Class D. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.